News
Strengthening its Doctor-Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / May 28, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed ...
Strand Therapeutics Announces Initial First-in-human Phase 1 Data for STX-001 in Patients with Advanced Solid Tumors at The 2025 ASCO Annual Meeting –Favorable safety and tolerability ...
Hosted on MSN29d
From Phase I to Phase II: Clone Armor ExplainedExplore the evolution of Clone Trooper armor from Phase I to Phase II, highlighting key design changes and tactical upgrades. This video breaks down the differences in helmet structure ...
At a recent city council meeting, it was announced that phase one of the project in Paso Robles is well underway. The latest completion is the curb and drive approaches outside of Way Side Liquor ...
Crusoe announced the second phase of construction, which includes six additional buildings, expanding the facility to eight buildings encompassing approximately 4 million square feet and a total power ...
PAS-004 demonstrated up to 91% inhibition of pERK, confirming strong target engagement, which is critical for evaluating the drug's effectiveness in treating MAPK pathway-driven cancers.
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second ...
KIITEE Phase 1 Results 2025 has been declared at kiitee.kiit.ac.in. The direct link to check is given below. The Kalinga Institute of Industrial Technology, KIIT, has declared the KIITEE 2025 ...
Haigh said the deconstruction, and construction of a new stadium, were all part of Phase 1 of the project, expected to take almost two and a half years, while Phase 2 will entail the building of a ...
Manipal Academy of Higher Education (MAHE) has declared the MET 2025 Phase 1 results for BTech admissions. The exam was held on April 18 and 19 in computer-based mode, with a total of 240 marks.
On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity. The results showed that the cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results